華測(ce)檢(jian)測(ce)認證集團股(gu)(gu)份有(you)(you)限公(gong)(gong)(gong)司旗下(xia)子公(gong)(gong)(gong)司——上海華測(ce)品(pin)創(chuang)醫學檢(jian)測(ce)有(you)(you)限公(gong)(gong)(gong)司與(yu)廣州維奧康藥(yao)(yao)業科技(ji)有(you)(you)限公(gong)(gong)(gong)司在廣州舉行股(gu)(gu)權交割儀式，華測(ce)品(pin)創(chuang)宣布完成(cheng)對(dui)維奧康藥(yao)(yao)業100%股(gu)(gu)權收購，維奧康藥(yao)(yao)業正式成(cheng)為華測(ce)品(pin)創(chuang)全資(zi)子公(gong)(gong)(gong)司。該交易將進一步完善CTI華測(ce)檢(jian)測(ce)在藥(yao)(yao)學CMC研究，包(bao)括藥(yao)(yao)物(wu)合成(cheng)、藥(yao)(yao)品(pin)處(chu)方與(yu)生產(chan)工藝開發(fa)、質(zhi)量(liang)研究、穩定性研究以及藥(yao)(yao)品(pin)的(de)注冊申報全鏈條(tiao)服務能力的(de)布局。(醫藥(yao)(yao)健(jian)聞)